FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Wall Street Journal2d
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...
devdiscourse13d
Healthcare Transformations: Navigating Challenges in Drug Pricing and Patient Safety
Current health news highlights include debates over Medicare pricing for drugs like Ozempic and Wegovy, management shifts ...
AOL10d
LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
Novo Nordisk, meanwhile, faced a 5% share price decline on Friday after outgoing U.S. president Joe Biden announced the company’s semaglutide drug, the medication used in Wegovy and Ozempic ...